Lidocaine in the treatment of decompression illness: A review of the literature

Undersea and Hyperbaric Medicine

Volumn 28, Issue 3, 2001, Pages 165-174

  Mitchell, S J ^a  

^a Wesley Ctr for Hyperbaric Medicine   (Australia)

Author keywords

Arterial gas embolism; Decompression illness; Decompression sickness; Lidocaine; Lignocaine; Neuro protection; Recompression

Indexed keywords

LIDOCAINE; NEUROPROTECTIVE AGENT;

BRAIN EMBOLISM; CELL HYPOXIA; DECOMPRESSION SICKNESS; DRUG EFFECT; ENERGY METABOLISM; HUMAN; METABOLISM; NERVE CELL; REVIEW;

CELL HYPOXIA; DECOMPRESSION SICKNESS; ENERGY METABOLISM; HUMANS; INTRACRANIAL EMBOLISM; LIDOCAINE; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 0035453219     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Moon RE, Gorman DF. Treatment of the decompression disorders. In: Bennett PB, Elliott DH, eds. The physiology and medicine of diving. London: WB Saunders, 1993:506-541.
2. Gardner M, Forbes C, Mitchell SJ. One hundred cases of decompression illness treated in New Zealand during 1995. SPUMS J 1996; 26:222-226.
3. Richardson K, Mitchell SJ, Davis MF, Richards M. Decompression illness in New Zealand Divers: the 1996 experience. SPUMS J 1998; 28:50-55.
4. Evans DE, Kobrine AI, LeGrys DC, Bradley ME. Protective effect of lidocaine in acute cerebral ischemia induced by air embolism. J Neurosurg 1984; 60:257-263.
5. Francis TJR, Gorman DF. Pathogenesis of the decompression disorders. In: Bennett PB, Elliott DH, eds. The physiology and medicine of diving. London: WB Saunders, 1993:454-480.
6. Hoffman BF, Bigger JT. Antiarrhythmic drugs. In: Goodman-Gilman A, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. New York: McGraw-Hill, 1991.
7. Sakurai M, Mannen T, Kanazawa I, Tanabe H. Lidocaine unmasks silent demyelinative lesions in multiple sclerosis. Neurology 1992; 42:2088-2092.
8. Evans DE, Kobrine AI, FlynnET, Bradley ET. Treatment of cardiovascular dysfunction resulting from cerebral air embolism. In: Bachrach AJ, ed. Proceedings of the VIIth symposium on underwater and hyperbaric physiology. Bethesda, MD: Undersea and Hyperbaric Medical Society, 1980:14.
9. Evans DE, Kobrine AI, Weathersby PK, Bradley ME. Cardiovascular effects of air embolism. Stroke 1981; 12:338-344.
10. Evans DE, Carton PW, McDermott JJ, Thomas LB, Kobrine AI, Flynn ET. Effect of lidocaine after experimental cerebral ischemia induced by air embolism. J Neurosurg 1989; 70:97-102.
11. McDermott JJ, Dutka AJ, Evans DE, Flynn ET. Treatment of experimental cerebral air embolism with lidocaine and hyperbaric oxygen (HBO). Undersea Biomed Res 1990; 17:525-534.
12. Dutka AJ, Mink R, McDermott JJ, Clark JB, Hallenbeck JM. Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism, Stroke 1992; 23:1515-1521.
13. Anonymous. US Navy diving manual Washington DC: Navy Department, 1979:8-25.
14. Broome JR, Dick EJ. Neurologic decompression illness in swine. Aviat Space Environ Med 1996; 67:207-213.
15. Gelb AW, Steinberg GK, Lam AM, Manninen PH, Peerless SJ, Rassi-Neto A. The effects of a prophylactic dose of lidocaine in focal cerebral ischemia. Can J Anaesth 1988; 35:480-493.
16. Nagao S, Murota T, Momma F, Kuyama H, Nishimoto A. The effect of intravenous lidocaine on experimental brain edema and neural activities. J Trauma 1988; 28:1650-1655.
17. Sutherland G, Ong BY, Louw D, Sima AAF. Effect of lidocaine on forebrain ischemia in rabbits. Stroke 1989; 20:119-122.
18. Lantos J, Sarosi I, Temes G, Torok B. Influence of protective drugs on the EEG during short-term transient ischemia. Acta Physiol Hung 1990; 75:217-227.
19. Shokunbi MT, Gelb AW, Wu XM, Miller DJ. Continuous lidocaine infusion and focal feline cerebral ischemia. Stroke 1990; 21:107-111.
20. Rasool N, Faroqui M, Rubenstein EH. Lidocaine accelerates neuroelectric recovery after incomplete global ischemia in rabbits. Stroke 1990; 21:929-35.
21. Ayad M, Verity MA, Rubinstein EH. Lidocaine delays cortical ischemic depolarization: relationship to electrophysiologic recovery and neuropathology. J Neurosurg Anesthesiol 1994; 6:98-110.
22. Fujitani T, Adachi N, Miyazaki H et al. Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: a microdialysis study in Mongolian gerbils. Neurosci Lett 1994; 179:91-94.
23. Mizunuma T, Ohta S, Suzuki M. Subarachnoid administration of lidocaine reduces delayed neuronal damage due to forebrain ischemia in rats. Masui 1996; 45:421-427.
24. Zhou Y, Wang D, Du M, et al. Lidocaine prolongs the safe duration of circulatory arrest during deep hypothermia in dogs. Can J Anaesth 1988; 45:692-698.
25. Wang D, Wu X, Zhong Y et al. Effect of lidocaine on improving cerebral protection provided by retrograde cerebral perfusion: a neuropathologic study. J Cardiothorac Vasc Anesth 1999; 13:176-180.
26. Shokunbi MT, Gelb AW, Peerless SJ, Mervant M, Floyd P. An evaluation of the effect of lidocaine on experimental focal cerebral ischemia. Stroke 1986; 17:962-966.
27. Warner DS, Godersky JC, Smith M-L. Failure of pre-ischemic lidocaine administration to ameliorate global ischemic brain damage in the rat. Anesthesiology 1988; 63:73-78.
28. Kobrine AI, Evans DE, LeGrys DC, Yaffe LJ, Bradley ME. Effect of intravenous lidocaine on experimental spinal cord injury. J Neurosurg 1984; 60:596-601.
29. Haghighi SS, Chehrazi BB, Higgins RS, Remington WJ, Wagner FC. Effect of lidocaine on acute spinal cord injury. Neurosurgery 1987; 20:536-541.
30. Kobrine AI. Effect of lidocaine on acute spinal cord injury. Neurosurgery 1987; 20:541.
31. Oldfield EH, Friedman R, Kinsella T, et al. Reduction in radiation-induced brain injury by use of pentobarbital or lidocaine protection. J Neurosurg 1990; 72:737-744.
32. Muir JK, Lyeth BG, Hamm RJ, Ellis EF. The effect of acute cocaine or lidociane on behavioral function followoing fluid percussion brain injury in rats. J Neurotrauma 1995; 12:87-97.
33. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77:169-84
34. Urenjak J, Obrenovitch TP. Pharmacological modulation of voltage-gated Na+ channels: a rational and effective strategy against ischemic brain damage. Pharmacol Rev 1996; 48:21-67.
35. Astrup J, Skovsted P, Gjerris F, Sorenson HR. Increase in extracellular potassium in the brain during circulatory arrest: effects of hypothermia, lidocaine and thiopental. Anesthesiology 1981; 55:256-262.
36. Lantos J, Temes G, Kelemen D, Sarosi I, Torok B. Influence of protective drugs on the elevation of extracellular potassium ion concentration in the brain during ischemia. Acta Physiol Hung 1990; 76:49-59.
37. LoPachin RM, Gaughan CL, Lehning EJ, Weber ML, Taylor CP. Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons. Neuroscience 2001; 103:971-983.
38. Fried E, Amorim P, Chambers G, Cottrell JE, Kass IS. The importance of sodium for anoxic transmission damage in rat hippocompal slices: mechanisms of protection by lidocaine. J Physiol (Lond) 1995; 489:557-565.
39. Weber ML, Taylor CP. Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and, phenytoin without blockade of action potentials. Brain Res 1994; 664:167-177.
40. Taylor CP, Burke SP, Weber ML. Hippocampal slices: glutamate overflow and cellualr damage from ischemia are reduced by sodium-channel blockade. J Neurosci Methods 1995; 59:121-128.
41. Lantos J, Roth E, Temes G. Effects of lidocaine on cerebral lipid peroxidation and neutrophil activation following complete compression ischemia. Arch Int Pharmacodyn Ther 1996; 331:179-188.
42. Diaz L, Gomex A, Bustos G. Lidocaine reduces the hypoxiainduced release of an excitatory amino acid analog from rat striatal slices in superfusion. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19:943-953.
43. Probert AW, Borosky S, Marcoux FW, Taylor CP. Sodium channel modulators prevent oxygen and glucose deprivation injury and glutamate release in rat neocortical cultures. Neuropharmacology 1997; 36:1031-1038.
44. Zhang Y, Lipton P. Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+ dependent Ca2+ release from mitochondria J Neurosci 1999; 19:3307-3315.
45. Styss PK, Ransom BR, Waxman SG. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992; 67:236-240.
46. Michenfelder JD. The interdependency of of cerebral function and metabolic effects following massive doses of thiopental in the dog. Anesthesiology 1974; 41:231-236.
47. Obrenovitch TP. The ischemic penumbra: 20 years on. Cerebrovasc Brain Metab Rev 1995; 7:297-322.
48. Geddes IC, Quastel JH. Effects of local anesthetics on respiration of rat brain cortex. Anesthesiology 1956; 17:666-671.
49. Haschke RH, Fink BR. Lidocaine effects on brain mitochondrial metabolism in vitro. Anesthesiology 1975; 42:737-740.
50. Astrup J, Sorenson PM, Sorenson HR. Inhibition of cerebral oxygen and glucose consumption in the dog by hypothermia, pentobarbital, and lidocaine. Anesthesiology 1981; 55:263-268.
51. + transport in canine brain. Stroke 1981; 12:726-730.
52. Sakabe T, Maekawa T, Ishikawa T, Takeshita H. The effects of lidocaine on canine cerebral metabolism and circulation related to the EEG. Anesthesiology 1974; 40:433-441.
53. Tommasino C, Maekawa T, Shapiro HM. Local cerebral blood flow during lidocaine induced seizure. Anesthesiology 1986; 64:771-776.
54. Schmid-Schonbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987; 46:2397-2401.
55. Dutka AJ, Kochanek PM, Hallenbeck JM. Influence of granulocytopenia on canine cerebral ischemia induced by air embolism. Stroke 1989; 20:390-395.
56. Helps SC, Gorman DF. Air embolism of the brain in rabbits pretreated with mechlorethamine. Stroke 1991; 22:351-354.
57. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial dysfunction associated with ischemia and reperfusion. In: Biology of the leukotrienes. New York: New York Academy of Science, 1988.
58. Hoidal JR, White JG, Repine JE. Influence of cationic local anesthetics on the metabolism and ultrastructure of human alveolar macrophages. J Lab Clin Med 1979; 93:857-866.
59. Peck SL, Johnston RB, Horwitz LD. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. J Pharm Exp Ther 1985; 235:418-422.
60. Goldstein IM, Lind S, Hoffstein S, Weissman G. Influence of local anesthetics upon human polymorphonuclear leucocyte function in vitro. J Exp Med 1977; 146:483-493.
61. Hyvonen PM, Kowolik MJ. Dose-dependent suppression of the neurophil respiratory burst by lidocaine. Acta Anesthesiol Scand 1998; 42:565-569.
62. Giddon DB, Lindhe J. In vivo quantitation of local anesthetic suppression of leukocyte adherence. Am J Pathol 1972; 68:327-338.
63. Luostarinen V, Evers H, Lyytikainen M-T, Scheinin A, Wahlen A. Antithrombotic effects of lidocaine and related compounds on laser induced microvascular injury. Acta Anesth Scand 1981; 25:9-11.
64. MacGregor RR, Thorner RE, Wright DM. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980; 56:203-209.
65. Nishina K, Mikawa K, Takao Y, Shiga M, Maekawa N, Obara H. Intravenous lidocaine attenuates acute lung injury induced by hydrochloric acid aspiration in rabbits. Anesthesiology 1998; 88:1300-309.
66. Nicholson GL, Smith JR, Poste G. Effects of local anesthetics on cell morphology and membrane associated cytoskeletal organisation in BALB/3T3 cells. J Cell Biol 1976; 68:395-403.
67. Tomoda MK, Tsuchiya M, Ueda W, Hirakawa M, Utsumi K. Lidocaine inhibits stimulation-coupled responses of neutrophils and protein kinase C activity. Physiol Chem Phys Med NMR 1990; 22:199-210.
68. Evans DE, Kobrine AI. Reduction of experimental intracranial hypertension by lidocaine. Neurosurgery 1987; 20:542-547.
69. Tobias MD, Henry C, Augostides YG. Lidocaine and bupivacaine esert differential effects on whole blood coagulation. J Clin Anesth 1999; 11:52-55.
70. Donegan MF, Bedford RV. Intravenously administered lidocaine prevents intracranial hypertension during endotrachial suctioning. Anesthesiology 1980; 52:516-518.
71. Hamill JF, Bedford RF, Weaver DC, Colohan AR. Lidocaine before endotrachial intubation. Intravenous or laryngotracheal? Anesthesiology 1981; 55:578-581.
72. Bedford RF, Persing JA, Pobereskin L, Butler A. Lidocaine or thiopental for rapid control of intracranial hypertension? Anesth Analg (Cleve) 1980; 592:435-437.
73. Johns RA, DiFazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose dependant manner. Anesthesiology 1985; 2:141-144.
74. Artru F, Terrier A, Tixier S, Jourdan C, Deleuze R. Use of intravenous lidocaine in neuro-anesthesia and neuroresuscitation. Aggressologie 1991; 32:439-443 .
75. Gao CR. Cerebral protection in neurosurgical anesthesia. Chung Hua Wai Ko Tsa Chih 1991; 29:170-173.
76. Govier AV. Central nervous system complications after cardiopulmonary bypass. In: Tinker JH, ed. Cardiopulmonary Bypass: Current Concepts and Controversies. Philadelphia: WB Saunders, 1989:41-68.
77. Templehoff R, Cheng MA, Boulard G, Ravussin P. Cerebral protection: contribution of intravenous anesthetic agents. Ann Fr Anesth Reanim 1995; 14:129-133.
78. Drewry A, Gorman DF. Lidocaine as an adjunct to hyperbaric therapy in decompression illness: a case report. Undersea Biomed Res 1992; 19:187-190.
79. Cogar WB. Intravenous lidocaine as adjunctive therapy in the treatment of decompression illness. Ann Emerg Med 1997; 29:284-286.
80. Ball R. Effect of severity, time to recompression with oxygen, and re-treatment on outcome in 49 cases of spinal cord decompression sickness. Undersea Hyper Med 1993; 20:133-145.
81. Mutzbauer TS, Ermisch J, Tetzlaff K, Frey G, Lampl LA. Low dose lidocaine as adjunct for treatment of decompression illness (DCI). Undersea Hyper Med 1999; 26(suppl):A20.
82. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann Thorac Surg 1999; 67:1117-1124.
83. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994; 25:1393-1399.
84. Mitchell SJ, Willcox T, McDougall C, Gorman DF. Emboli generation by the Medtronic 25Maxima hardshell adult venous reservoir in cardio-pulmonary bypass circuits: a preliminary report Perfusion 1996; 11:145-155.
85. Milsom FP, Mitchell SJ. A novel dual vent heart de-airing technique markedly reduces carotid artery microemboli. Ann Thorac Surg 1998; 66:785-791.
86. Mitchell SJ, Pellett O, Gorman DF. Open chamber cardiac surgery: a clinical injury model for arterial gas embolism. SPUMS J 1997; 27:230-235.
87. Mitchell SJ, Benson M. Vadlamudi L, Miller P. Arterial gas embolism by helium: an unusual case successfully treated with hyperbaric oxygen and lidocaine. Ann Emerg Med 2000; 35:300-303.
88. Munson ES, Tucker WK, Ausisch B, Malagodi MH. Etidocaine, bupivacaine and lidocaine seizure thresholds in monkeys. Anesthesiology 1975; 42:471-478.
89. Ingvar M, Shapiro HM. Selective metabolic activation of the hippocampus during lidcaine induced pre-seizure activity. Anesthesiology 1981; 54:33-37.